IRhythm Technologies Net Income/Loss 2015-2025 | IRTC
IRhythm Technologies net income/loss from 2015 to 2025. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
| IRhythm Technologies Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2024 | $-113 |
| 2023 | $-123 |
| 2022 | $-116 |
| 2021 | $-101 |
| 2020 | $-44 |
| 2019 | $-55 |
| 2018 | $-50 |
| 2017 | $-30 |
| 2016 | $-21 |
| 2015 | $-23 |
| 2014 | $-16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.223B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.594B | 60.55 |
| Hims & Hers Health (HIMS) | United States | $12.830B | 133.30 |
| Doximity (DOCS) | United States | $11.392B | 52.74 |
| Tempus AI (TEM) | United States | $10.965B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.794B | 59.28 |
| Hinge Health (HNGE) | United States | $3.587B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.17 |
| 10x Genomics (TXG) | United States | $1.691B | 0.00 |
| Schrodinger (SDGR) | United States | $1.650B | 0.00 |
| Phreesia (PHR) | United States | $1.610B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.565B | 0.00 |
| Azenta (AZTA) | United States | $1.555B | 72.25 |
| Enovis (ENOV) | United States | $1.551B | 8.65 |
| Omnicell (OMCL) | United States | $1.318B | 23.25 |
| Evolent Health (EVH) | United States | $1.098B | 93.50 |
| Claritev (CTEV) | United States | $0.686B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Standard BioTools (LAB) | United States | $0.558B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Talkspace (TALK) | United States | $0.422B | 126.00 |
| TruBridge (TBRG) | United States | $0.349B | 775.00 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.268B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| CapsoVision (CV) | United States | $0.198B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.165B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| Pulmonx (LUNG) | United States | $0.133B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.106B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.82 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.085B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |